Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP
| Report ID | 29312 |
| Drug Identification Number | 02250276 |
| Brand name | CEFTRIAXONE SODIUM FOR INJECTION, BP |
| Common or Proper name | Ceftriaxone sodium |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10x250mg vial |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-11-13 |
| Estimated end date | |
| Actual end date | 2017-12-20 |
| Shortage status | Resolved |
| Updated date | 2017-12-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2018-02-02 | English | Compare |
| v10 | 2017-12-21 | French | Compare |
| v9 | 2017-12-21 | English | Compare |
| v8 | 2017-12-21 | French | Compare |
| v7 | 2017-12-21 | English | Compare |
| v6 | 2017-12-14 | French | Compare |
| v5 | 2017-12-14 | English | Compare |
| v4 | 2017-11-25 | English | Compare |
| v3 | 2017-11-15 | French | Compare |
| v2 | 2017-11-15 | English | Compare |
| v1 | 2017-11-15 | English | Compare |
Showing 1 to 11 of 11